News on haematological malignancies
New therapeutic target identified for rare virus-associated lymphomas
Targeting a “cell survival” protein could be a valuable new approach to treating certain blood…
Browsing: Haematology
FDA grants Fast Track designation to Calibr’s ‘switchable’ CAR-T cell cancer therapy
The U.S. Food and Drug Administration has granted Fast Track designation to a novel “switchable”…
An area of the brain where tumour cells shelter from chemotherapy in childhood leukaemia
The stroma of the choroid plexus is one of the locations within the central nervous…
Potential cause of immunotherapy-related neurotoxicity
New research has uncovered the previously unknown presence of CD19 — a B cell molecule…
ASH releases new clinical practice guidelines on acute myeloid leukaemia in older adults
ASH have published new guidelines to help older adults with acute myeloid leukaemia (AML) and…
Identified gene mutations impact on the severity of a type of haematologic cancer
The Myelodysplastic Syndromes Group of Josep Carreras Leukaemia Research Institute, Spain, led by Dr. Francesc…
Researchers seeks safer, more effective leukaemia treatment
A potentially safer, more effective chemotherapy treatment for patients with blood-related cancers, such as leukaemia,…
Excellent research results for CAR-T Cell therapy against Hodgkin lymphoma
CAR-T cell therapy, which attacks cancer cells using a person’s reprogrammed immune cells, has been…
Breakthrough with cancer vaccine
Scientists are ready to trial a new cancer vaccine in humans following the successful outcome…
Mapping the immune landscape of haematological cancers may help to enhance therapies
Activating the immune system of the body is a promising form of treatment for cancer.…